Over its 10 years, Tufts Clinical and Translational Science Institute (CTSI) has brought together purposefully-selected partners and has organized new and existing programs and activities with a singular purpose to best contribute to clinical and translational research (CTR). We focus on what we are best suited to do, based on our particular skills, resources, partners, and opportunities. Thereby, we have been able to provide unique and outstanding services, resources, education, and mentorship, locally, nationally, and to the field of CTR. With this application, we are pleased to be able to substantially grow our offerings by expanding our long-standing partners? contributions, and by adding the special assets of new partners. With growth, our guiding principles have not changed: 1) We actively support the full spectrum of translational research, and we insist that wherever on the T1-T4 continuum, CTR must have a clear line of sight to potential ultimate impact on health; 2) At all stages of research, we practice ?broadly-engaged team science.? For CTR to be relevant and impactful, research teams must have a wide array of stakeholders from inception to completion and dissemination; 3) We are active collaborators. We embrace our role as ?the extrovert CTSA.? We believe that connections among diverse disciplines, stakeholders, and organizations are synergistic on many levels. This has powered our hub, and our leadership of multiple CTSA Consortium activities; 4) We believe that only by having systems and processes to continually assess and to iteratively improve processes will we achieve CTR excellence. We have a signature program in research process improvement, which we apply across CTR, and which led to our leading the national roll-out of the CTSA Common Metrics; 5) We reflexively look for opportunities to contribute novel research methods. Development, demonstration, and dissemination of new methods and approaches are hallmarks of our work, regardless of domain; 6) Rigorous role-specific education and training are fundamental to excellence in, and advancing, CTR. In service of these principles, our aims are: Overall AIM 1) Create an environment, resources, and services to stimulate and support the full spectrum of CTR by leveraging the diverse expertise and assets of Tufts CTSI partners. Overall AIM 2) Cultivate broadly-engaged team science, actively including stakeholders, to promote relevant and impactful translation for diverse populations and across the lifespan. Overall AIM 3) Develop, demonstrate, and disseminate innovations in methods, research process improvement, and evaluation, to advance CTR locally and nationally. Overall AIM 4) Advance methods and performance of multi-site clinical trials, within the Tufts CTSI Clinical Research Network, the NCATS Trial Innovation Network, and in other multi-institutional networks. Overall AIM 5) Provide outstanding education, training, and mentoring, tailored to different roles and disciplines, to advance a diverse CTR workforce, and share these resources nationally.
Through research resources, services, and education, Tufts Clinical and Translational Science Institute supports the entire spectrum of clinical and translational research to help meet the promise and the public?s needs of biomedical science. This spectrum includes the translation of bench research into bedside care (?T1?), into effective clinical practice (?T2?), into wide care delivery and public health (?T3?), and into health policy (?T4?). By doing this, we hope to support research that will have impact on healthcare and the public?s health.
| Bugaev, Nikolay; McKay, Kevin; Breeze, Janis L et al. (2017) Self-Inflicted Abdominal Stab Wounds Have a Higher Rate of Non-therapeutic Laparotomy/Laparoscopy and a Lower Risk of Injury. World J Surg 41:2681-2688 |
